Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A
- PMID: 3536746
- PMCID: PMC260231
- DOI: 10.1128/iai.54.3.735-741.1986
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A
Abstract
The capsule of Cryptococcus neoformans is an important virulence factor. In this investigation capsular polysaccharides (CPSs) were isolated by ethanol precipitation from culture filtrates of C. neoformans serotype A strains 6, 15, 98, 110, and 145. Capsule sizes on India ink examination ranged from barely perceptible (strain 15) to greater than the diameter of the yeast cell (strain 6); the others were intermediate in size. On ion-exchange chromatography on DEAE-cellulose each CPS eluted at 0.2 M NaCl; CPS of strain 15 had two major peaks, designated III and IV. On gel-permeation chromatography CPSs of strains 6, 98, 110, and 145 eluted at the void volume of Sepharose CL-2B in the presence or 0.1 M EDTA, while the CPS of strain 15 eluted in two peaks. Sephacryl S-1000 resolved CPSs of all five strains in the following order, from largest to smallest molecular size: 145 greater than 110 greater than 98 greater than 6 much greater than 15. All five CPSs contained mannose, xylose, and glucuronic acid, while the carboxyl-reduced CPS of strain 110 also contained a large percentage of an inositol-like compound. The CPS of strain 110 contained approximately 30% uronic acid by weight, while the others had 15 to 20%. The composition of peak IV from the CPS of strain 15 resembled those of the other strains; peak III of strain 15 contained a substantial amount of galactose. Each CPS contained less than 0.2% protein by weight. The significant differences in molecular size and sugar composition among CPSs of these strains of C. neoformans serotype A may partially explain strain differences in virulence and biological properties of the organism.
Similar articles
-
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.Infect Immun. 1986 Dec;54(3):742-50. doi: 10.1128/iai.54.3.742-750.1986. Infect Immun. 1986. PMID: 3536747 Free PMC article.
-
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.Infect Immun. 1989 Dec;57(12):3751-6. doi: 10.1128/iai.57.12.3751-3756.1989. Infect Immun. 1989. PMID: 2680980 Free PMC article.
-
Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.Microbiol Immunol. 1991;35(2):125-38. doi: 10.1111/j.1348-0421.1991.tb01540.x. Microbiol Immunol. 1991. PMID: 1886490
-
Capsular polysaccharides of Cryptococcus neoformans.Rev Infect Dis. 1984 Sep-Oct;6(5):619-24. doi: 10.1093/clinids/6.5.619. Rev Infect Dis. 1984. PMID: 6209768 Review.
-
Soluble polysaccharides of Cryptococcus neoformans.Curr Top Med Mycol. 1988;2:40-54. doi: 10.1007/978-1-4612-3730-3_2. Curr Top Med Mycol. 1988. PMID: 3288362 Review. No abstract available.
Cited by
-
Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.J Clin Invest. 1997 Sep 15;100(6):1640-6. doi: 10.1172/JCI119688. J Clin Invest. 1997. PMID: 9294133 Free PMC article.
-
Molecular typing of Cryptococcus neoformans serotype D clinical isolates.J Clin Microbiol. 1994 Oct;32(10):2364-71. doi: 10.1128/jcm.32.10.2364-2371.1994. J Clin Microbiol. 1994. PMID: 7814467 Free PMC article.
-
Current concepts in cryptococcosis.Eur J Clin Microbiol Infect Dis. 1989 May;8(5):457-65. doi: 10.1007/BF01964060. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2502410 Review.
-
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes.Infect Immun. 1991 Jan;59(1):24-8. doi: 10.1128/iai.59.1.24-28.1991. Infect Immun. 1991. PMID: 1987038 Free PMC article.
-
Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.Infect Immun. 1993 Feb;61(2):464-9. doi: 10.1128/iai.61.2.464-469.1993. Infect Immun. 1993. PMID: 8423074 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources